Abstract
Neuropeptides control a wide spectrum of physiological functions. They are central to our understanding of brain functions. They exert their actions by interacting with specific G protein-coupled receptors. We however have not found all the neuropeptides that exist in organisms. The search for novel neuropeptides is thus of great interest as it will lead to a better understanding of brain function and disorders. In this review, we will discuss the historical as well as the current approaches to neuropeptide discovery, with a particular emphasis on the orphan GPCR-based strategies. We will also discuss two novel peptides, neuropeptide S and neuromedin S, as examples of the impact of neuropeptide discovery on our understanding of brain functions. Finally, the challenges facing neuropeptide discovery will be discussed.
Keywords: Neuropeptide, Orphan GPCR, Neuropeptide S, Neuromedin S, neurotransmitters, homeostasis, caffeine, signal transduction, amino ac, suprachiasmatic nucleus (SCN), secondary, angiogenesis, neurogenesis, functional, recovery, endogenuis, exogenius, factors, dedifferentiation, pluripotent, multipotent, Proliferation, Survival, Precursor cells
Current Pharmaceutical Design
Title: Novel Neuropeptides as Ligands of Orphan G Protein-Coupled Receptors
Volume: 17 Issue: 25
Author(s): Yan Zhang, Zhiwei Wang, Gregory Scott Parks and Olivier Civelli
Affiliation:
Keywords: Neuropeptide, Orphan GPCR, Neuropeptide S, Neuromedin S, neurotransmitters, homeostasis, caffeine, signal transduction, amino ac, suprachiasmatic nucleus (SCN), secondary, angiogenesis, neurogenesis, functional, recovery, endogenuis, exogenius, factors, dedifferentiation, pluripotent, multipotent, Proliferation, Survival, Precursor cells
Abstract: Neuropeptides control a wide spectrum of physiological functions. They are central to our understanding of brain functions. They exert their actions by interacting with specific G protein-coupled receptors. We however have not found all the neuropeptides that exist in organisms. The search for novel neuropeptides is thus of great interest as it will lead to a better understanding of brain function and disorders. In this review, we will discuss the historical as well as the current approaches to neuropeptide discovery, with a particular emphasis on the orphan GPCR-based strategies. We will also discuss two novel peptides, neuropeptide S and neuromedin S, as examples of the impact of neuropeptide discovery on our understanding of brain functions. Finally, the challenges facing neuropeptide discovery will be discussed.
Export Options
About this article
Cite this article as:
Zhang Yan, Wang Zhiwei, Scott Parks Gregory and Civelli Olivier, Novel Neuropeptides as Ligands of Orphan G Protein-Coupled Receptors, Current Pharmaceutical Design 2011; 17 (25) . https://dx.doi.org/10.2174/138161211797416110
DOI https://dx.doi.org/10.2174/138161211797416110 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Reactive Oxygen Species in Pathogenesis of Atherosclerosis
Current Pharmaceutical Design Fabrication and Characterization of Ocular Phase Transition Systems for Blepharitis: A Novel Approach
Drug Delivery Letters High-risk Pregnancy and Perinatal Outcome: An Observational Study
Current Women`s Health Reviews The Critical Role of Insulin-Like Growth Factor-1 Isoforms in the Physiopathology of Skeletal Muscle
Current Genomics Epidemiology of Upper Gastrointestinal Damage Associated with Low-Dose Aspirin
Current Pharmaceutical Design How Should We Treat Hypertension and Dyslipidemia in Patients with Prediabetes?
Current Pharmaceutical Design Non-Alcoholic Fatty Pancreas Disease (NAFPD): A Silent Spectator or the Fifth Component of Metabolic Syndrome? A Literature Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Antithrombotic Treatment Management in Patients with Intracerebral Hemorrhage: Reversal and Restart
Current Pharmaceutical Design An Overview of Emerging Immunotargets of Genitourinary Tumors
Current Drug Targets Anthocyanins: Plant Pigments, Food Ingredients or Therapeutic Agents for the CNS? A Mini-Review Focused on Clinical Trials
Current Pharmaceutical Design Development of Nitrendipine Nanoliposome for Transdermal Drug Delivery: Preparation, Characterization and Permeation Studies
Drug Delivery Letters Role of Physician Gender in the Quality of Care of Cardiometabolic Diseases
Current Pharmaceutical Design Importance of Pharmacology Knowledge by Dieticians
Current Nutrition & Food Science Sildenafil for Antenatal Treatment of Congenital Diaphragmatic Hernia: From Bench to Bedside
Current Pharmaceutical Design Nailfold Capillaroscopy Within and Beyond the Scope of Connective Tissue Diseases
Current Rheumatology Reviews Targeting Vascular Endothelial Growth Factor Pathway in First-Line Treatment of Metastatic Colorectal Cancer: State-of-the-Art and Future Perspectives in Clinical and Molecular Selection of Patients
Current Cancer Drug Targets Renoprotection with Anti-Hypertensives: Reduction of Proteinuria and Improvement of Oxygenation via Inhibition of the Renin-Angiotensin System
Current Hypertension Reviews Targeting TRP Channels in Airway Disorders
Current Topics in Medicinal Chemistry Vasopressin-Receptor Antagonists: A New Class of Agents for the Treatment of Hyponatremia
Endocrine, Metabolic & Immune Disorders - Drug Targets Cognitive Decline as a Consequence of Essential Hypertension
Current Pharmaceutical Design